The Correlation Between the Treatment Efficacy and the Sympathetic Activity in Men With Lower Urinary Tract Symptoms
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: In this study, we examined the difference in the treatment efficacy depending on the sympathetic activity in men with lower urinary tract symptoms (LUTS). Methods: In the current single-center, retrospective study, we evaluated a total of 66 male patients aged 40–70 years of age, presenting with LUTS, whose International Prostate Symptom Score (IPSS) exceeded 8 points. They had a past 3-month history of taking alfuzosin XL, and their heart rate variability (HRV) was measured before and after the treatment. In addition, we also recruited 39 healthy volunteers who visited a health promotion center for a regular medical check-up. They were aged between 40 and 70 years and had an IPSS of <8 points. We divided the patients with LUTS into two groups: the groups A and B, based on a low frequency/high frequency (LF/HF) ratio of 1.7, which was the mean value of the LF/HF ratio in the healthy volunteers. After a 3-month treatment with alfuzosin XL, we compared treatment outcomes, based on the IPSS and peak urine flow rate, between the two groups. Results: A 3-month treatment with alfuzosin XL, comprising the measurement of the HRV, was performed for the 23 patients of the group A (23/38) and 17 of the group B (17/28). After a 3-month treatment with alfuzosin XL, total IPSS and IPSS questionnaire 2 and 5 were significantly lower in the group A as compared with the group B. But this was not seen in the group B. Furthermore, there were no significant differences in other parameters, such as maximal flow rate and IPSS storage subscore, between the two groups. Conclusions: Our results indicate that the treatment efficacy was lower in patients with sympathetic hyperactivity as compared with those with sympathetic hypoactivity. Thus, our results will provide a basis for further studies to clarify causes of LUTS in a clinical setting.
Abstract
Purpose: In this study, we examined the difference in the treatment efficacy depending on the sympathetic activity in men with lower urinary tract symptoms (LUTS). Methods: In the current single-center, retrospective study, we evaluated a total of 66 male patients aged 40–70 years of age, presenting with LUTS, whose International Prostate Symptom Score (IPSS) exceeded 8 points. They had a past 3-month history of taking alfuzosin XL, and their heart rate variability (HRV) was measured before and after the treatment. In addition, we also recruited 39 healthy volunteers who visited a health promotion center for a regular medical check-up. They were aged between 40 and 70 years and had an IPSS of <8 points. We divided the patients with LUTS into two groups: the groups A and B, based on a low frequency/high frequency (LF/HF) ratio of 1.7, which was the mean value of the LF/HF ratio in the healthy volunteers. After a 3-month treatment with alfuzosin XL, we compared treatment outcomes, based on the IPSS and peak urine flow rate, between the two groups. Results: A 3-month treatment with alfuzosin XL, comprising the measurement of the HRV, was performed for the 23 patients of the group A (23/38) and 17 of the group B (17/28). After a 3-month treatment with alfuzosin XL, total IPSS and IPSS questionnaire 2 and 5 were significantly lower in the group A as compared with the group B. But this was not seen in the group B. Furthermore, there were no significant differences in other parameters, such as maximal flow rate and IPSS storage subscore, between the two groups. Conclusions: Our results indicate that the treatment efficacy was lower in patients with sympathetic hyperactivity as compared with those with sympathetic hypoactivity. Thus, our results will provide a basis for further studies to clarify causes of LUTS in a clinical setting.
참고문헌 (23)
- McVary KT, "Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia", J Urol, 174(4 Pt 1), pp.1327~1433 (2005)
- Ushijima S, "Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score", J Urol, 176, pp.665~671 (2006)
- Choi JB, "Characteristics of autonomic nervous system activity in men with lower urinary tract symptoms(LUTS) : analysis of heart rate variability in men with LUTS", Urology, 75, pp.138~142 (2010)
- Hubeaux K, "Evidence for autonomic nervous system dysfunction in females with idiopathic overactive bladder syndrome", Neurourol Urodyn, 30, pp.1467~1472 (2011)
- Liao WC, "A noninvasive evaluation of autonomic nervous system dysfunction in women with an overactive bladder", Int J Gynaecol Obstet, 110, pp.12~17 (2010)
- Ben-Dror I, "Alterations of heart rate variability in women with overactive bladder syndrome", Int Urogynecol J, 23, pp.1081~1086 (2012)
- Kirby MG, "Overactive bladder: is there a link to the metabolic syndrome in men?", Neurourol Urodyn, 29, pp.1360~1364 (2010)
- Bushman W, "Etiology, epidemiology, and natural history of benign prostatic hyperplasia", Urol Clin North Am, 36, pp.403~415 (2009)
- McConnell JD, "The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia", N Engl J Med, 349, pp.2387~2398 (2003)
- Meigs JB, "Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men", J Clin Epidemiol, 54, pp.935~944 (2001)
- "Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use", Eur Heart J, 17, pp.354~381 (1996)
- Silvetti MS, "Heart rate variability in healthy children and adolescents is partially related to age and gender", Int J Cardiol, 81, pp.169~174 (2001)
- Choi JB, "Analysis of heart rate variability in female patients with overactive bladder", Urology, 65, pp.1109~1112 (2005)
- Akselrod S, "Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control", Science, 213, pp.220~222 (1981)
- Pomeranz B, "Assessment of autonomic function in humans by heart rate spectral analysis", Am J Physiol, 248(1 Pt 2), pp.H151~H153 (1985)
- Malliani A, "Cardiovascular neural regulation explored in the frequency domain", Circulation, 84, pp.482~492 (1991)
- Kamath MV, "Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function", Crit Rev Biomed Eng, 21, pp.245~311 (1993)
- Rimoldi O, "Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs", Am J Physiol, 258(4 Pt 2), pp.H967~H976 (1990)
- Montano N, "Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt", Circulation, 90, pp.1826~1831 (1994)
- 오동근, "The Difference of Lower Urinary Tract Symptoms Between Sympathetic Hyperactive and Hypoactive Men", International Neurourology Journal, 17(1), pp.30~33 (2013), 대한배뇨장애요실금학회[DOI]
- Boyle P, "The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study", BJU Int, 92, pp.409~414 (2003)
- Fowke JH, "Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume", BJU Int, 111, pp.122~128 (2013)
- Harte CB, "Association between smoking and heart rate variability among individuals with depression", Ann Behav Med, 46, pp.73~80 (2013)